Role of immunosuppressive therapy in neuroendocrine activation after human heart, renal, and liver transplantation

Author： Piquard F. Geny B. Elero B. Canguilhem B. Mettauer B. Epailly E. Chakfe N. Charpentier A. Wolf P. Kretz J.G. Eisenmann B. Koehl C. Haberey P.

Publisher： Elsevier

ISSN： 0041-1345

Source： Transplantation Proceedings, Vol.30, Iss.5, 1998-08, pp. : 2124-2126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tailoring immunosuppressive therapy in renal transplantation

By Vathsala A.

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2478-2479

Elsevier

Access to resources Recommend Favorite

FK 506 as Primary Immunosuppressive Therapy in Renal Transplantation

By Preston R. Ball S. Cairns T. Contis J. Hakim N. Palmer A. Papalois V. Taube D.

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1214-1215

Elsevier

Access to resources Recommend Favorite

Risk factors in renal transplantation and implications for immunosuppressive therapy

By Halloran P.F.

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 351-352

Elsevier

Access to resources Recommend Favorite

Analysis of the adverse effects of immunosuppressive therapy in heart transplantation

By Almenar-Bonet L. Rueda-Soriano J. Osa-Saez A. Arnau-Vives M.A. Martinez-Dolz L. Gisbert F.D. Palencia-Perez M.

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 134-136

Elsevier

Access to resources Recommend Favorite

Usefulness of monitoring of AUC 0-4h during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation

By Uchida K. Tominaga Y. Haba T. Katayama T. Matsuoka S. Sato T. Goto N. Takeda A. Morozumi K. Takagi H.

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1736-1737

Elsevier

Access to resources Recommend Favorite